Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Cord Neoplasms | 4 | 2018 | 263 | 1.180 |
Why?
|
Ependymoma | 2 | 2017 | 320 | 0.870 |
Why?
|
Neurosurgical Procedures | 7 | 2024 | 2072 | 0.450 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1745 | 0.450 |
Why?
|
Meningeal Neoplasms | 3 | 2018 | 1248 | 0.410 |
Why?
|
Neurosurgery | 3 | 2023 | 679 | 0.350 |
Why?
|
Decompression, Surgical | 3 | 2017 | 607 | 0.290 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 916 | 0.290 |
Why?
|
Meningioma | 1 | 2015 | 1218 | 0.270 |
Why?
|
Spinal Neoplasms | 2 | 2023 | 716 | 0.260 |
Why?
|
RNA | 1 | 2016 | 2726 | 0.260 |
Why?
|
Brain Neoplasms | 8 | 2022 | 9031 | 0.250 |
Why?
|
Famous Persons | 2 | 2016 | 109 | 0.240 |
Why?
|
Drug Delivery Systems | 3 | 2024 | 2226 | 0.230 |
Why?
|
Fetal Proteins | 1 | 2024 | 98 | 0.230 |
Why?
|
Arteriovenous Malformations | 2 | 2016 | 396 | 0.210 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3801 | 0.200 |
Why?
|
Chordoma | 1 | 2024 | 347 | 0.180 |
Why?
|
Spinal Cord Compression | 1 | 2023 | 235 | 0.180 |
Why?
|
Clarithromycin | 1 | 2021 | 86 | 0.180 |
Why?
|
Specialties, Surgical | 1 | 2024 | 389 | 0.160 |
Why?
|
Dimethyl Sulfoxide | 2 | 2016 | 251 | 0.160 |
Why?
|
Hallucinations | 1 | 2021 | 366 | 0.150 |
Why?
|
Embolization, Therapeutic | 3 | 2017 | 1418 | 0.150 |
Why?
|
Cranial Nerves | 1 | 2017 | 98 | 0.140 |
Why?
|
Cerebral Arteries | 2 | 2017 | 490 | 0.140 |
Why?
|
Vertebral Artery | 1 | 2017 | 185 | 0.130 |
Why?
|
Spondylosis | 1 | 2016 | 84 | 0.130 |
Why?
|
Arnold-Chiari Malformation | 1 | 2017 | 158 | 0.130 |
Why?
|
Cell-Free System | 1 | 2016 | 340 | 0.130 |
Why?
|
Dura Mater | 1 | 2017 | 290 | 0.130 |
Why?
|
Glioma | 2 | 2022 | 3455 | 0.120 |
Why?
|
Glioblastoma | 2 | 2022 | 3482 | 0.120 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 750 | 0.120 |
Why?
|
Artificial Intelligence | 3 | 2024 | 2578 | 0.120 |
Why?
|
Aneuploidy | 1 | 2017 | 552 | 0.110 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2017 | 366 | 0.110 |
Why?
|
Leadership | 1 | 2023 | 1385 | 0.110 |
Why?
|
Astrocytoma | 1 | 2018 | 775 | 0.110 |
Why?
|
Social Isolation | 1 | 2015 | 364 | 0.100 |
Why?
|
Blood-Brain Barrier | 2 | 2018 | 1027 | 0.100 |
Why?
|
Brain Stem | 1 | 2017 | 858 | 0.100 |
Why?
|
Prejudice | 1 | 2015 | 570 | 0.100 |
Why?
|
Haplotypes | 1 | 2017 | 2713 | 0.090 |
Why?
|
Arterial Occlusive Diseases | 1 | 2015 | 748 | 0.090 |
Why?
|
Self-Assessment | 2 | 2023 | 397 | 0.090 |
Why?
|
Craniotomy | 1 | 2015 | 741 | 0.090 |
Why?
|
DNA, Mitochondrial | 1 | 2016 | 865 | 0.090 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1779 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1745 | 0.090 |
Why?
|
Wakefulness | 1 | 2017 | 1265 | 0.090 |
Why?
|
Single-Cell Analysis | 2 | 2018 | 2450 | 0.080 |
Why?
|
Sports | 1 | 2016 | 705 | 0.080 |
Why?
|
Anesthesia, General | 1 | 2017 | 1174 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 822 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1496 | 0.080 |
Why?
|
Age Distribution | 1 | 2015 | 2880 | 0.080 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1474 | 0.080 |
Why?
|
Humans | 35 | 2024 | 761572 | 0.080 |
Why?
|
Bioreactors | 1 | 2010 | 247 | 0.080 |
Why?
|
Collagen | 1 | 2017 | 2638 | 0.080 |
Why?
|
Mutation | 3 | 2018 | 30054 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3639 | 0.080 |
Why?
|
Deep Brain Stimulation | 1 | 2017 | 832 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2917 | 0.070 |
Why?
|
Spine | 2 | 2024 | 1118 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3615 | 0.070 |
Why?
|
Spinal Fusion | 1 | 2016 | 1286 | 0.070 |
Why?
|
Heart Arrest | 1 | 2016 | 1514 | 0.070 |
Why?
|
Tendons | 1 | 2010 | 558 | 0.070 |
Why?
|
Databases, Factual | 3 | 2016 | 7967 | 0.070 |
Why?
|
Athletic Injuries | 1 | 2016 | 1216 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2015 | 2244 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21017 | 0.060 |
Why?
|
Odds Ratio | 3 | 2023 | 9646 | 0.060 |
Why?
|
Brain Injuries | 1 | 2016 | 2053 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8633 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13642 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2023 | 2707 | 0.050 |
Why?
|
Treatment Outcome | 7 | 2018 | 64684 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2877 | 0.050 |
Why?
|
Seizures | 1 | 2015 | 2957 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7407 | 0.050 |
Why?
|
Search Engine | 1 | 2023 | 143 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1600 | 0.050 |
Why?
|
T-Box Domain Proteins | 1 | 2024 | 469 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10553 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5672 | 0.050 |
Why?
|
Male | 13 | 2024 | 360842 | 0.050 |
Why?
|
Skull Base Neoplasms | 1 | 2024 | 270 | 0.040 |
Why?
|
Logistic Models | 1 | 2015 | 13255 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2010 | 1868 | 0.040 |
Why?
|
Epilepsy | 1 | 2015 | 3290 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Cohort Studies | 3 | 2017 | 41493 | 0.040 |
Why?
|
Fibroblasts | 1 | 2010 | 4141 | 0.040 |
Why?
|
Spinal Diseases | 1 | 2024 | 564 | 0.040 |
Why?
|
Female | 13 | 2024 | 392686 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5315 | 0.040 |
Why?
|
Demography | 1 | 2024 | 1648 | 0.040 |
Why?
|
Neoplasms | 2 | 2018 | 22173 | 0.040 |
Why?
|
Adult | 6 | 2022 | 221203 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18398 | 0.040 |
Why?
|
Middle Aged | 6 | 2022 | 220920 | 0.040 |
Why?
|
History, 20th Century | 2 | 2016 | 2767 | 0.040 |
Why?
|
Radiosurgery | 2 | 2018 | 1342 | 0.040 |
Why?
|
Superior Sagittal Sinus | 1 | 2017 | 15 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5709 | 0.040 |
Why?
|
United States | 4 | 2024 | 72335 | 0.040 |
Why?
|
Microbubbles | 1 | 2018 | 135 | 0.030 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2018 | 246 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2023 | 80646 | 0.030 |
Why?
|
History, 15th Century | 1 | 2015 | 29 | 0.030 |
Why?
|
History, Medieval | 1 | 2015 | 62 | 0.030 |
Why?
|
History, 16th Century | 1 | 2015 | 70 | 0.030 |
Why?
|
History, 17th Century | 1 | 2015 | 108 | 0.030 |
Why?
|
Karyotyping | 1 | 2017 | 1171 | 0.030 |
Why?
|
Russia | 1 | 2016 | 384 | 0.030 |
Why?
|
Community Health Planning | 1 | 2016 | 164 | 0.030 |
Why?
|
History, Ancient | 1 | 2015 | 212 | 0.030 |
Why?
|
Government | 1 | 2016 | 161 | 0.030 |
Why?
|
Polyvinyls | 1 | 2016 | 154 | 0.030 |
Why?
|
History, 18th Century | 1 | 2015 | 207 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 2018 | 464 | 0.030 |
Why?
|
Prognosis | 3 | 2022 | 29629 | 0.030 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2023 | 1163 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2490 | 0.030 |
Why?
|
Stroke | 1 | 2016 | 9758 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1638 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2456 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 847 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36429 | 0.030 |
Why?
|
Hemostatics | 1 | 2016 | 241 | 0.030 |
Why?
|
Genomic Instability | 1 | 2017 | 709 | 0.030 |
Why?
|
History, 19th Century | 1 | 2015 | 720 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2018 | 13382 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2865 | 0.030 |
Why?
|
Aged | 4 | 2022 | 169310 | 0.030 |
Why?
|
Incidental Findings | 1 | 2017 | 697 | 0.030 |
Why?
|
Cattle | 1 | 2017 | 3849 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2017 | 1768 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58986 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1432 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3579 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2016 | 1115 | 0.020 |
Why?
|
Face | 1 | 2016 | 1026 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2016 | 980 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2020 | 0.020 |
Why?
|
Tensile Strength | 1 | 2010 | 330 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1567 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14666 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4111 | 0.020 |
Why?
|
Animals | 5 | 2024 | 168467 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2020 | 0.020 |
Why?
|
Adolescent | 4 | 2018 | 88324 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3511 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5915 | 0.020 |
Why?
|
Tendon Injuries | 1 | 2010 | 328 | 0.020 |
Why?
|
Nanoparticles | 1 | 2018 | 1959 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2057 | 0.020 |
Why?
|
Random Allocation | 1 | 2010 | 2395 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16986 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 2656 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2010 | 1674 | 0.020 |
Why?
|
Extremities | 1 | 2010 | 867 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3877 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16592 | 0.010 |
Why?
|
Genome, Human | 1 | 2017 | 4425 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2017 | 15633 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4772 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12725 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6426 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26127 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 23996 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20099 | 0.010 |
Why?
|
Child | 2 | 2018 | 80156 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13510 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6935 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39107 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42230 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20571 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18253 | 0.010 |
Why?
|
Brain | 1 | 2018 | 27120 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 59255 | 0.010 |
Why?
|
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_